Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VNLS

Vernalis (VNLS)

Vernalis Plc ADS (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VNLS
DateTimeSourceHeadlineSymbolCompany
11/12/200618:00PR Newswire (US)Vernalis plc Initiates a Phase I Trial of a Promising New Approach to Treating Obesity and Related Disorders - Including Type IINASDAQ:VNLS
21/11/200618:00PR Newswire (US)Vernalis plc to Present at the 18th Annual Piper Jaffray Healthcare Conference in New York on November 30, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
20/11/200618:00PR Newswire (US)Vernalis plc Announces Progress on Its Oncology Hsp90 ProgrammeNASDAQ:VNLS
02/11/200618:00PR Newswire (US)Vernalis to Present at Cowen and Company 7th Annual Global Health Care ConferenceNASDAQ:VNLS
20/09/200623:31PR Newswire (US)Vernalis plc to Present at UBS Global Life Sciences Conference on September 26, 2006NASDAQ:VNLSVernalis Plc ADS (MM)
20/09/200620:30PR Newswire (US)Vernalis plc Announces FDA Acceptance for Filing of Frova(R) for Short-Term Prevention of Menstrual MigraineNASDAQ:VNLS
12/09/200617:00PR Newswire (US)Vernalis Plc: Interim Results for the Six Months Ended 30 June 2006NASDAQ:VNLS
20/07/200608:00PR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLSVernalis Plc ADS (MM)
20/07/200608:00PR Newswire (US)Endo Pharmaceuticals and Vernalis plc Announce the Filing of the Supplemental NDA for Frova(R) for Short-Term Prevention of MenNASDAQ:VNLS
19/06/200621:00PR Newswire (US)Vernalis plc to Present at Investor Conferences During June 2006NASDAQ:VNLSVernalis Plc ADS (MM)
18/05/200603:00PR Newswire (US)Vernalis plc [VNLS] CEO to Ring the NASDAQ Stock Market Closing BellNASDAQ:VNLSVernalis Plc ADS (MM)
15/05/200617:00PR Newswire (US)Vernalis plc to Ring the NASDAQ Closing Bell on May 18, 2006NASDAQ:VNLS
08/05/200617:00PR Newswire (US)Frova(R) Meets Primary Endpoint in Second Phase III Study for Prevention of Menstrual MigraineNASDAQ:VNLS
15/07/200408:50PR Newswire (US)Endo Licenses Rights from Vernalis to Market Acute Migraine Treatment Frova(TM)NASDAQ:VNLS
30/03/200422:00PR Newswire (US)Vernalis Regains Control of North American Rights To Frovatriptan From ElanNASDAQ:VNLSVernalis Plc ADS (MM)
30/03/200422:00PR Newswire (US)Vernalis plc: Preliminary Results for the Eight Months Ended 31 December 2003NASDAQ:VNLS
 Showing the most relevant articles for your search:NASDAQ:VNLS

Your Recent History

Delayed Upgrade Clock